GS Spacer

Auckland Bone and Joint Research Group

The issue

As New Zealand’s population ages, skeletal health issues such as osteoporosis and arthritis are having a major impact on quality of life.

The solution

The Auckland Bone and Joint Research Group is a world-leading research partnership which has pioneered major medical breakthroughs in the treatment of osteoporosis, Paget’s disease, and gout.

The ‘Bone Group’ has its origins in the Department of Endocrinology at the then Auckland Hospital in the 1980s. Today it is a highly successful partnership between leading researchers at the University of Auckland Faculty of Medical and Health Sciences and the Auckland District Health Board.

The Group’s research is broad and includes population genetics of osteoporosis, Paget’s disease and gout.


The internationally recognised research of the Bone Group has led to it securing patents for novel bone/cartilage/tendon growth factors.

The Group has had a succession of major research achievements, which directly impact on the day-to-day lives of patients worldwide.

These include the use of bisphonates to treat osteoporosis, a ‘cure’ for Paget’s disease with zoledronate, the establishment of the effectiveness of calcium supplements on bone density and the discovery of increased cardiovascular risk with those same supplements.